An investigation by The New York Times has revealed widespread problems in the rapidly expanding autism therapy clinic industry, which serves thousands of young children across the United States.

The investigation found that many clinics are overprescribing treatment to children with autism, with some preschoolers spending up to 40 hours per week at these facilities. This intensive schedule often involves short naps and long hours for children as young as two and three years old.

The rapid growth of the industry has strained state Medicaid budgets, as these clinics primarily rely on government funding to operate. Investigators found evidence of systematic overbilling practices, with some facilities charging for services not provided or billing for excessive hours of treatment.

The focus on maximizing revenue has led to documented cases of fraud within the industry. Some clinics have been found to prioritize financial considerations over appropriate treatment protocols, potentially compromising the quality of care provided to vulnerable children.

The investigation also uncovered instances where the intensive treatment schedules and billing-focused approach resulted in actual harm to children. Experts have raised concerns about whether the current model of care prioritizes quantity over quality in autism treatment.

State regulators are now examining the industry more closely as concerns mount about both the financial impact on public health programs and the welfare of the children receiving services at these facilities.